Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-07

Clinical Trial Update: Psychopharmacological Treatment of Emotional Distress [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update indicates a psychopharmacological treatment for emotional distress, including Suicide Crisis Syndrome and psychological distress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Suicide Crisis Syndrome, Psychological Distress | Phase 4 | Status: RECRUITING